The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
David Plante1, Ron Grunstein2, Giuseppe Plazzi3, Kiran Maski4, Jandira Ramos5, Yangchun Du5, Alexandra Lovett5, Marcus Yountz5, Bhaskar Rege5
1University of Wisconsin School of Medicine and Public Health, Madison, United States, 2Woolcock Institute of Medical Research, Macquarie University and Sydney Health Partners, Sydney, Australia, 3IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy, 4Boston Children’s Hospital, Department of Neurology, Boston, United States, 5Alkermes, Inc., Waltham, United States
